Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01124461 : BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PhaseN/A
AgesMin: 18 Years Max: 70 Years
Eligibility
Inclusion Criteria:

- Patients will be enrolled in this clinical trial pre-operatively anticipating a
surgical resection with anticipation that the patient carries a likely diagnosis of
malignant glioma.

- Patients will only be enrolled if it is anticipated that the resection will give
significant tissue for subsequent genetic analysis (1 cm of tumor tissue)

- If patients at surgery are found to carry an alternative tissue diagnosis, the
patient's preoperative imaging, clinical, and pathological information will be
uploaded into the database, but the patient will not be counted as one of the
participants

- Ability to undergo serial MR studies

- Enrollment KPS > 70

- Anticipation that surgery will allow subtotal resection or gross total resection,
facilitating removal of tissue specimens for genomic analysis.

Exclusion Criteria:

- Inability to participate in serial MR studies

- KPS < 70

- > 70 years of age
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01124461      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740